National HealthCare officer plans $600,817 stock sale

NATIONAL HEALTHCARE CORP (NHC) is named as the issuer in a Form 144 notice filed for the planned sale of common stock beneficially owned by officer Josh A. McCreary.

Available on EDGAR 09/10/2026 - 02:23 PM EDT Accepted by SEC EDGAR 09/10/2026 - 02:23 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

NATIONAL HEALTHCARE CORP (NHC) is named as the issuer in a Form 144 notice filed for the planned sale of common stock beneficially owned by officer Josh A. McCreary. The filing reports a proposed sale of 2,719 shares of NHC common stock, with an aggregate market value of $600,817.00, through Janney Montgomery Scott on the NYSE, in reliance on Rule 144.

The shares derive from prior equity compensation, including restricted stock vesting on January 1, 2022 and multiple stock option exercises in 2023 and 2024 via net exercise transactions. The filing also lists 15,661,395 shares of NHC common stock as outstanding as of September 10, 2026 as a reference figure.

Key Figures

Shares proposed to be sold: 2,719 shares Aggregate market value of proposed sale: $600,817.00 Shares outstanding: 15,661,395 shares +4 more

7 metrics

Shares proposed to be sold 2,719 shares Common stock of NATIONAL HEALTHCARE CORP reported in the Form 144 notice

Aggregate market value of proposed sale $600,817.00 Total market value of 2,719 NHC shares covered by the Form 144

Shares outstanding 15,661,395 shares NHC common shares outstanding as of September 10, 2026, listed as a reference figure

Restricted stock vesting 259 shares Common stock acquired on January 1, 2022 through restricted stock vesting

Stock option exercise on November 21, 2023 437 shares Common stock acquired via net exercise of options granted February 18, 2022

Stock option exercise on February 29, 2024 822 shares Common stock acquired via net exercise of options granted February 18, 2022

Stock option exercise on June 12, 2024 1,201 shares Common stock acquired via net exercise of options granted March 8, 2023

Key Terms

Rule 144, Restricted Stock Vesting, Net Exercise

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Vesting financial

"Common | 01/01/2022 | Restricted Stock Vesting | Issuer"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

Net Exercise financial

"Common | 11/21/2023 | Exercise Stock Option Granted 2/18/2022 |"

A net exercise is a way to convert stock options into shares without paying cash up front: instead of handing over money to buy the optioned shares, the holder receives only the number of shares equal to the option’s value after the company withholds a portion of shares to cover the exercise price and taxes. It matters to investors because it changes how many new shares are issued, affects dilution of existing shareholders, and alters company cash flow compared with a cash exercise.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing disclose for NATIONAL HEALTHCARE CORP (NHC)?

The Form 144 filing discloses that officer Josh A. McCreary may sell 2,719 shares of NATIONAL HEALTHCARE CORP common stock under Rule 144, with an aggregate market value of $600,817.00, through broker Janney Montgomery Scott on the NYSE.

How many NATIONAL HEALTHCARE CORP (NHC) shares are proposed to be sold and at what value?

The filing reports a proposed sale of 2,719 shares of NATIONAL HEALTHCARE CORP common stock with an aggregate market value of $600,817.00, as indicated in the securities information section of the Form 144.

Who is selling NATIONAL HEALTHCARE CORP (NHC) shares under this Form 144 notice?

The Form 144 notice is filed for the account of Josh A. McCreary, identified as an officer of NATIONAL HEALTHCARE CORP, in connection with a potential sale of 2,719 shares of the company’s common stock under Rule 144.

How were the NATIONAL HEALTHCARE CORP (NHC) shares to be sold acquired?

The 2,719 NHC shares were acquired through equity compensation: a restricted stock vesting on January 1, 2022 for 259 shares and stock option exercises on November 21, 2023, February 29, 2024, and June 12, 2024 totaling 2,460 shares via net exercise transactions.

What reference share count for NATIONAL HEALTHCARE CORP (NHC) is included in the Form 144?

The Form 144 includes a reference figure of 15,661,395 shares of NATIONAL HEALTHCARE CORP common stock outstanding as of September 10, 2026, which serves as a baseline context for the size of the proposed sale.

Which broker and market are involved in the planned sale of NATIONAL HEALTHCARE CORP (NHC) shares?

The proposed sale of NATIONAL HEALTHCARE CORP common stock is listed as being through Janney Montgomery Scott, with the shares to be sold on the NYSE, as specified in the securities information section of the Form 144.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001774116
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	NATIONAL HEALTHCARE CORP
SEC File Number	001-13489
Address of Issuer	100 E. VINE ST MURFREESBORO TENNESSEE 37130
Phone	6158902020
Name of Person for Whose Account the Securities are To Be Sold	McCreary Josh A
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Janney Montgomery Scott 1717 Arch St Philadelphia PA 19103	2719	600817.00	15661395	09/10/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/01/2022	Restricted Stock Vesting	Issuer			259	01/01/2022	Compensation
Common	11/21/2023	Exercise Stock Option Granted 2/18/2022	Issuer			437	11/21/2023	Net Exercise
Common	02/29/2024	Exercise Stock Option Granted 2/18/2022	Issuer			822	02/29/2024	Net Exercise
Common	06/12/2024	Exercise Stock Option Granted 3/8/2023	Issuer			1201	06/12/2024	Net Exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	09/10/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Josh A. McCreary
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)